Stockreport

Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update [Yahoo! Finance]

Armata Pharmaceuticals, Inc.  (ARMP) 
PDF focused on high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial resu [Read more]